Cargando…
Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity
Methylmalonic aciduria and homocystinuria, cobalamin C (cblC) type, is the most common genetic type of functional cobalamin (vitamin B(12)) deficiency. This metabolic disease is characterized by marked heterogeneity of neurocognitive disease (microcephaly, seizures, developmental delay, ataxia, hypo...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368212/ https://www.ncbi.nlm.nih.gov/pubmed/27289364 http://dx.doi.org/10.1007/s00467-016-3399-0 |
_version_ | 1782517883036762112 |
---|---|
author | Beck, Bodo B. van Spronsen, FrancJan Diepstra, Arjan Berger, Rolf M. F. Kömhoff, Martin |
author_facet | Beck, Bodo B. van Spronsen, FrancJan Diepstra, Arjan Berger, Rolf M. F. Kömhoff, Martin |
author_sort | Beck, Bodo B. |
collection | PubMed |
description | Methylmalonic aciduria and homocystinuria, cobalamin C (cblC) type, is the most common genetic type of functional cobalamin (vitamin B(12)) deficiency. This metabolic disease is characterized by marked heterogeneity of neurocognitive disease (microcephaly, seizures, developmental delay, ataxia, hypotonia) and variable extracentral nervous system involvement (failure to thrive, cardiovascular, renal, ocular) manifesting predominantly early in life, sometimes during gestation. To enhance awareness and understanding of renal disease associated with cblC defect, we studied biochemical, genetic, clinical, and histopathological data from 36 patients. Consistent clinical chemistry features of renal disease were intravascular hemolysis, hematuria, and proteinuria in all patients, with nephrotic-range proteinuria observed in three. Renal function ranged from normal to renal failure, with eight patients requiring (intermittent) dialysis. Two thirds were diagnosed with atypical (diarrhea-negative) hemolytic uremic syndrome (HUS). Renal histopathology analyses of biopsy samples from 16 patients revealed glomerular lesions typical of thrombotic microangiopathy (TMA). Treatment with hydroxycobalamin improved renal function in the majority, including three in whom dialysis could be withdrawn. Neurological sequelae were observed in 44 % and cardiopulmonary involvement in 39 % of patients, with half of the latter group demonstrating pulmonary hypertension. Mortality reached 100 % in untreated patients and 79 and 56 % in those with cardiopulmonary or neurological involvement, respectively. In all patients presenting with unclear intravascular hemolysis, hematuria, and proteinuria, cblC defect should be ruled out by determination of blood/plasma homocysteine levels and/or genetic testing, irrespective of actual renal function and neurological status, to ensure timely diagnosis and treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00467-016-3399-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5368212 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-53682122017-04-11 Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity Beck, Bodo B. van Spronsen, FrancJan Diepstra, Arjan Berger, Rolf M. F. Kömhoff, Martin Pediatr Nephrol Review Methylmalonic aciduria and homocystinuria, cobalamin C (cblC) type, is the most common genetic type of functional cobalamin (vitamin B(12)) deficiency. This metabolic disease is characterized by marked heterogeneity of neurocognitive disease (microcephaly, seizures, developmental delay, ataxia, hypotonia) and variable extracentral nervous system involvement (failure to thrive, cardiovascular, renal, ocular) manifesting predominantly early in life, sometimes during gestation. To enhance awareness and understanding of renal disease associated with cblC defect, we studied biochemical, genetic, clinical, and histopathological data from 36 patients. Consistent clinical chemistry features of renal disease were intravascular hemolysis, hematuria, and proteinuria in all patients, with nephrotic-range proteinuria observed in three. Renal function ranged from normal to renal failure, with eight patients requiring (intermittent) dialysis. Two thirds were diagnosed with atypical (diarrhea-negative) hemolytic uremic syndrome (HUS). Renal histopathology analyses of biopsy samples from 16 patients revealed glomerular lesions typical of thrombotic microangiopathy (TMA). Treatment with hydroxycobalamin improved renal function in the majority, including three in whom dialysis could be withdrawn. Neurological sequelae were observed in 44 % and cardiopulmonary involvement in 39 % of patients, with half of the latter group demonstrating pulmonary hypertension. Mortality reached 100 % in untreated patients and 79 and 56 % in those with cardiopulmonary or neurological involvement, respectively. In all patients presenting with unclear intravascular hemolysis, hematuria, and proteinuria, cblC defect should be ruled out by determination of blood/plasma homocysteine levels and/or genetic testing, irrespective of actual renal function and neurological status, to ensure timely diagnosis and treatment. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00467-016-3399-0) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-06-11 2017 /pmc/articles/PMC5368212/ /pubmed/27289364 http://dx.doi.org/10.1007/s00467-016-3399-0 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Beck, Bodo B. van Spronsen, FrancJan Diepstra, Arjan Berger, Rolf M. F. Kömhoff, Martin Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity |
title | Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity |
title_full | Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity |
title_fullStr | Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity |
title_full_unstemmed | Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity |
title_short | Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity |
title_sort | renal thrombotic microangiopathy in patients with cblc defect: review of an under-recognized entity |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5368212/ https://www.ncbi.nlm.nih.gov/pubmed/27289364 http://dx.doi.org/10.1007/s00467-016-3399-0 |
work_keys_str_mv | AT beckbodob renalthromboticmicroangiopathyinpatientswithcblcdefectreviewofanunderrecognizedentity AT vanspronsenfrancjan renalthromboticmicroangiopathyinpatientswithcblcdefectreviewofanunderrecognizedentity AT diepstraarjan renalthromboticmicroangiopathyinpatientswithcblcdefectreviewofanunderrecognizedentity AT bergerrolfmf renalthromboticmicroangiopathyinpatientswithcblcdefectreviewofanunderrecognizedentity AT komhoffmartin renalthromboticmicroangiopathyinpatientswithcblcdefectreviewofanunderrecognizedentity |